novo tirzepatide Nordisk's STEER Study: Wegovy Cuts Cardiovascular Risk 57 % vs. Learn more about Tirzepatide_Industry News_Senova

Glucagon-like peptide-1 (GLP-1) agonists, traditionally derived synthetically, are pivotal in managing type 2 diabetes and obesity due to their ability to enhance insulin secretion and promote satiety

Report severe: Abdominal pain Persistent vomiting Signs of hypoglycemia Sudden mood changes What Tests And Follow-Up Your Clinician Should Consider Before starting: Pregnancy test Fasting glucose or HbA1c Fasting insulin, if available Lipid panel Liver tests Thyroid history review Documentation of contraception or pregnancy plans Early follow-up at 2 to 4 weeks can assess tolerability and dose titration

Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, Yang C, Liu HF

Alcohol can cause your blood sugar to be too low or too high

We cover the main differences between Zepbound and Wegovy below

Any researcher who purchased products from Paradigm Peptides should verify those products through independent testing before use